Harvard/NIH: Cannabis Derivative and Pancreatic Cancer Potential, July 2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663976/ Abstract: This study reports on a new non-cannabinoid, non-psychoactive derivative of cannabis, termed FBL-03G, with the potential to treat pancreatic cancer. In vivo results demonstrate therapeutic efficacy in delaying both local and metastatic tumor progression in animal models with pancreatic cancer when using FBL-03G sustainably…
Read more Harvard/NIH: Cannabis Derivative and Pancreatic Cancer Potential »